The fact that executives often take psychedelics to “turn on, tune in and quit” is old news. Reports that the houses of Facebook, Apple, Google, and Twitter are swimming with Type-A professionals who are actively looking to expand their minds, boost creativity, and leapfrog the competition microdosed magic mushrooms and LSD were part of what sparked the microdosing trend in the first place.
According to a report by The Wall Street Journal, Tesla and Neuralink CEO Elon Musk takes ketamine while Google founder Sergey Brin prefers psilocybin mushrooms.
According to Magazine, some sources who remain anonymous reportedly said they witnessed or were told by the billionaire himself that he takes small doses of ketamine to treat depression, while larger doses of the dissociative were preferred for social events.
Shortly after the report, the Tesla CEO tweeted that taking ketamine occasionally is a better option than traditional treatments for depression, citing the experience of friends. He has also taken a stand against SSRIs, which are some of the most popular pharmaceutical drugs prescribed for depression. Depression is overdiagnosed in the United States, but for some people it’s really a brain chemistry problem, she wrote. But the zombification of people with SSRIs definitely happens too much.
Elon Musk tweets “Depression is overdiagnosed in the US, but for some people it really is a brain chemistry problem…”
Because ketamine, when taken in large doses, can produce a psychedelic experience, drug regulators have been hesitant to approve it for depression; however, its ability to quickly and effectively treat symptoms of depression has led many doctors and clinics to prescribe the treatment off-label. One of the most recent studies published in the New England Journal of Medicine, involving 403 patients, found that 55% of those receiving ketamine treatment had sustained improvement in depressive symptoms without major side effects.
Esketamine, a derivative of ketamine, was approved by the Food and Drug Administration (FDA) as a drug for treatment-resistant depression (TRD) in March 2019 and for major depression and suicide in August 2020. This version is marketed as branded nasal spray Spraved and demonstrated an improvement in depressive symptoms after only a single dose.
Read also: Released a new guide for the use of ketamine and esketamine therapy
This isn’t the first time the eccentric billionaire has taken the psychedelic Twitter community by storm. While he hasn’t spoken bluntly about his personal experiences with psychedelics, there has been speculation about Musk’s possible use of these drugs to fuel his success, with Musk tweeting repeatedly about DMT. In 2019 he he tweeted a meme on DMT and Area 51. Later, in 2020, so is he tweeted the following: Laws of thermodynamics: 1. You can’t win. 2. You can’t break even. 3. You can’t stop playing. Unless you’re on DMT.
Despite Musk making many cryptic pro-psychedelic comments in the past, a tweet in 2022 has become one of the most explicit acknowledgments that he believes in the therapeutic power of these mind-altering substances. In response to Twitter userMarc Andressenwho asked how prescribed psychedelics replacing amphetamines and SSRIs would change our society, the CEO of SpaceX and Technoking replied, “I’ve talked to far more people who have been helped by psychedelics and ketamine than SSRIs and amphetamines “.
Read also: Elon Musk wows psychedelic industry CEOs with tweet
The Wall Street Journal also reported that Musk isn’t alone among the tech billionaires who rely on psychedelics to improve their lives and potentially help with business breakthroughs: Google co-founder Sergey Brin allegedly uses psilocybin mushrooms, which they are now legal in Colorado and Oregon for therapeutic purposes. use and decriminalized in several US cities.
You may also like: Where are psilocybin mushrooms legal or decriminalized in the world?
“Elon Musk stepping forward at this moment shows what a watershed moment the Psychedelic Science 2023 conference really was, he normalized psychedelic medicine and made it safe to talk about,” said Zappy Zapolin, award-winning director and star psychedelic concierge .
“Having top athletes like Aaron Rodgers, the Democratic governor of Colorado, and former Republican governor of Texas, Rick Perry all speak enthusiastically about psychedelic medicine for mental health and addiction crises has helped finally normalize these treatments.” said Zapolin, who has worked with ibogaine with NBA star and famed Kardashian Lamar Odom.
During the 2023 Psychedelic Science conference in Denver, Aaron Rodgers told an enthusiastic crowd that there have been “hundreds” of NFL players who have reached out to him about ayahuasca, seeking to learn more about his psychedelic journey with the plant. medicinal. The five-day event, hosted by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS), attracted more than 11,000 people, ranging from medical professionals to politicians, celebrities and business professionals. clinical trials examining psychedelic therapy for hospice patients, demonstrating growing cultural awareness and acceptance of psychedelic medicines.
“Encouraged by the media coverage of the event, Elon Musk probably felt comfortable sharing his controversial thinking that ketamine is a better alternative to SSRIs,” Zappy commented. “What excites me is that both Elon Musk and Sam Altman have made it clear that the core of the large AI language models they are developing will adequately represent the benefits of psychedelic medicines,” he touted.
Zapolin points out that, post-pandemic, every family, including celebrities, is battling addiction-related or mental health issues and “are turning to these types of treatments, knowing now that organizations like John’s Hopkins, Yale and MAPS have already demonstrated their safety and efficacy. The psychedelic concierge says his phone “exploded recently and even more since Psychedelics Science ended.” “People are looking for real solutions,” he explained.
Zappy told Psychedelic Spotlight that, lately, he’s been getting inquiries not only from Silicon Valley companies, but also from New York City hedge funds, Los Angeles media and entertainment companies. “Many executives are now looking to group sessions to foster compassion and empathy among their teams and ensure everyone is aligned. It has become the responsibility of companies and talent agents to prioritize the mental well-being of their employees and clients, psychedelic medicine offers not only the possibility for improvement but also significant improvements in this regard,” he stressed.
We live in exciting times; once demonized in the 1960s, these substances are now slowly but surely painting a different canvas that illustrates their therapeutic potential. Australia has already changed the classification of psilocybin and MDMA to allow licensed psychiatrists to prescribe the drugs for the treatment of PTSD and depression, effective July 1 this year. It’s only a matter of time before North America follows in the footsteps of the Land Down Under.
#Elon #Musk #Takes #Ketamine #Manage #Depression #Report #Psychedelic #spotlight
Image Source : psychedelicspotlight.com